R. Lasala

发表

Patient Adherence and Persistence with Imatinib, Nilotinib, Dasatinib in Clinical Practice

P. Sorice, A. Costantini, F. Santoleri, 2013, PloS one.

Adherence to and effectiveness of lenalidomide after 1 year of treatment in a real world setting

M. Rocchi, S. Pulini, A. Morelli, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Medication Adherence, Persistence and Cost in Multiple Sclerosis Patients: Oral vs Parenteral Treatment

A. Costantini, F. Santoleri, R. Lasala, 2016 .

Precision Medicine in the Treatment of Locally Advanced or Metastatic Urothelial Cancer: New Molecular Targets and Pharmacological Therapies

A. Vitiello, Francesco Ferrara, A. Zovi, 2022, Cancers.

A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions.

P. Vici, N. Petragnani, A. Costantini, 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Dosage adjustments in pivotal clinical trials with oral targeted therapies in solid tumors conducted in Europe

A. Costantini, F. Santoleri, R. Lasala, 2019, European Journal of Clinical Pharmacology.

Leuprorelin and Triptorelin in the treatment of Prostate Cancer: Medication adherence, Persistence and Economic Evaluation in Five Years of Analysis

P. Sorice, F. Santoleri, R. Lasala, 2014 .

Time factor in antiretroviral adherence: analysis of adherence to single-tablet regimens versus multiple-tablet regimens over a 5-year period

A. Ammazzalorso, M. Fantacuzzi, R. Amoroso, 2018, Drugs & Therapy Perspectives.

Time factor in antiretroviral adherence: analysis of adherence to single-tablet regimens versus multiple-tablet regimens over a 5-year period

A. Ammazzalorso, M. Fantacuzzi, R. Amoroso, 2018 .

Medication adherence and persistence in the treatment of rheumatoid arthritis with adalimumab and etanercept. Six years of analysis

P. Sorice, A. Costantini, F. Santoleri, 2014, Journal of medical economics.

Medication adherence reporting in pivotal clinical trials: overview of oral oncological drugs

A. Costantini, F. Santoleri, R. Lasala, 2022, European journal of hospital pharmacy : science and practice.

Medication Adherence to Tyrosine Kinase Inhibitors: 2-Year Analysis of Medication Adherence to Imatinib Treatment for Chronic Myeloid Leukemia and Correlation with the Depth of Molecular Response

P. Di Bartolomeo, A. Costantini, Elena Ranucci, 2016, Acta Haematologica.

Safety and Effectiveness of Multiple Switching Between Originators and Biosimilars: Literature Review and Status Report on Interchangeability

A. Zovi, F. Santoleri, R. Lasala, 2022, Therapeutic Innovation & Regulatory Science.

Using a treatment diary to improve the medication adherence in patients with chronic myeloid leukaemia

A. Costantini, Elena Ranucci, F. Santoleri, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Randomized clinical trials and real life studies: Comparison of baseline characteristics of patients in oral target therapies for renal cell carcinoma

A. Costantini, F. Santoleri, R. Lasala, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Dosage adjustments in pivotal clinical trials with oral targeted therapies in solid tumors conducted in Europe

A. Costantini, F. Santoleri, R. Lasala, 2019, European Journal of Clinical Pharmacology.

Available information about paediatric use of onco-haematological drugs authorized by EMA since 2016

D. Zanon, A. Costantini, F. Santoleri, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Association between adherence to oral therapies in cancer patients and clinical outcome: A systematic review of the literature

F. Santoleri, R. Lasala, 2021, British journal of clinical pharmacology.

Liraglutide vs Exenatide: Patient Adherence, Medication Persistence and Economic Evaluation in the Treatment of Type 2 Diabetes Mellitus

P. Sorice, A. Costantini, F. Santoleri, 2014 .

ADA_ETA_BIO2021: real-world evaluation of adherence, persistence, and cost-effectiveness of originator and biosimilar biologic drugs in the treatment of rheumatoid arthritis: a multicenter study in Italy

A. Costantini, F. Santoleri, Letizia Di Fabio, 2023, Current Medical Research and Opinion.

Time to treatment discontinuation in first-line non-small cell lung carcinoma: an overview

V. Isgró, A. Zovi, F. Santoleri, 2023, Current Medical Research and Opinion.

Anti-CGRP mAbs for the Preventive Treatment of Migraine: An Overview Review and a Cost Saving Analysis in the Global Scenario

U. Musazzi, R. Lasala, Andrea Zovi, 2023, Hospital pharmacy.

The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer.

P. Polidori, A. Costantini, F. Santoleri, 2024, European journal of clinical pharmacology.

Cancer drugs for solid tumors approved by the EMA since 2014: an overview of pivotal clinical trials

A. Costantini, F. Santoleri, R. Lasala, 2020, European Journal of Clinical Pharmacology.

Dietary management and access to treatment for patients with glucose deficiency syndrome type 1: an overview review with focus on the European regulatory framework.

S. Vittori, R. Lasala, Antonio Vitiello, 2024, European journal of clinical nutrition.

Antidepressant deprescribing: State of the art and recommendations—A literature overview

F. Santoleri, R. Lasala, A. Romagnoli, 2024, European journal of clinical pharmacology.